Department of Pharmaceutical Sciences, University of Florence, Sesto Fiorentino, Florence, Italy.
Electrophoresis. 2010 Oct;31(19):3296-304. doi: 10.1002/elps.201000066.
A dual system of CDs was used for the first time in MEEKC with the aim of determining clemastine and its three main related impurities in both drug substances and tablets. The addition of methyl-β-cyclodextrin and heptakis(2,6-di-O-methyl)-β-cyclodextrin to the microemulsion pseudo-stationary phase was essential to increase the resolving power of the system to obtain a baseline separation among the compounds. The best microemulsion composition was identified by mixture design and the effects of the factors concentrations of CDs and voltage were investigated by a response surface study applying a Central Composite Design. In both cases, Derringer's desirability function made it possible to find the global optimum, which corresponded to the following combination: microemulsion, 89.8% 10 mM borate buffer pH 9.2, 1.5% n-heptane and 8.7% of SDS/n-butanol in 1:2 ratio; 18 mM methyl-β-cyclodextrin, 38 mM heptakis(2,6-di-O-methyl)-β-cyclodextrin, 17 kV. By applying these conditions, the separation was completed in about 5.5 min. The method was validated following International Conference on Harmonisation guidelines and was applied to a real sample of clemastine tablets.
首次在 MEKC 中使用双 CD 体系,旨在测定药物原料和片剂中的氯苯那敏及其三种主要相关杂质。在微乳液拟固定相添加甲基-β-环糊精和七(2,6-二-O-甲基)-β-环糊精,对于提高系统的分辨率,实现化合物的基线分离至关重要。通过混合设计确定最佳微乳液组成,并通过响应面研究(应用中心复合设计)考察 CD 和电压的因素浓度的影响。在这两种情况下,Derringer 的理想函数都可以找到全局最优值,对应于以下组合:微乳液,89.8% 10 mM 硼酸缓冲液 pH 9.2,1.5%正庚烷和 SDS/n-丁醇 1:2 比,8.7%;18 mM 甲基-β-环糊精,38 mM 七(2,6-二-O-甲基)-β-环糊精,17 kV。在这些条件下,分离在大约 5.5 分钟内完成。该方法按照国际协调会议的指导方针进行了验证,并应用于氯苯那敏片剂的实际样品。